Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Co-Diagnostics Inc

CODX
Current price
1.03 USD 0 USD (0.00%)
Last closed 1.06 USD
Sector Healthcare
Industry Medical Devices
Exchange NASDAQ
Capitalization 32 532 664 USD
Yield for 12 month -3.74 %
1Y
3Y
5Y
10Y
15Y
CODX
21.11.2021 - 28.11.2021

Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah. Address: 2401 South Foothill Drive, Salt Lake City, UT, United States, 84109

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

2 USD

P/E ratio

Dividend Yield

Current Year

+991 473 USD

Last Year

+34 218 209 USD

Current Quarter

+252 745 USD

Last Quarter

+3 555 177 USD

Current Year

-4 423 950 USD

Last Year

+28 737 117 USD

Current Quarter

-312 333 USD

Last Quarter

+274 458 USD

Key Figures CODX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -41 792 888 USD
Operating Margin TTM -2192.86 %
PE Ratio
Return On Assets TTM -26.4 %
PEG Ratio
Return On Equity TTM -41.16 %
Wall Street Target Price 2 USD
Revenue TTM 6 677 935 USD
Book Value 2.51 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -22.3 %
Dividend Yield
Gross Profit TTM 28 737 117 USD
Earnings per share -1.31 USD
Diluted Eps TTM -1.31 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY 30.8 %
Profit Margin

Dividend Analytics CODX

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History CODX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation CODX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 16
Enterprise Value Revenue 0.1837
Price Sales TTM 5.5067
Enterprise Value EBITDA 0.4502
Price Book MRQ 0.4288

Financials CODX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators CODX

For 52 weeks

0.98 USD 1.89 USD
50 Day MA 1.15 USD
Shares Short Prior Month 454 722
200 Day MA 1.18 USD
Short Ratio 5.97
Shares Short 315 488
Short Percent 1.04 %

Dynamics of changes in the value of assets

Stocks


MSFT

MSFT

430.16 USD Microsoft Corporation +3.16 (+0.74%)
Detailed analytics

ETF funds


S

SX7EEX

14.70 EUR iShares EURO STOXX Banks 30-15 UCITS ETF (DE) +0.1 (+0.64%)
Detailed analytics

Metals


Gold

2357.98 USD Gold +6.23 (+0.27%)
Detailed analytics